CD274 and neoplasm: Furthermore, NR2F6 downregulation sensitizes tumors to established PD-1/PD-L1 axis blockade to prevent tumor progression due to the positive correlation between NR2F6 expression and the T-cell dysfunction/exhaustion phenotype [23].